cd91 on antigen-presenting cells influences response to nascent tumors
Published 5 years ago • 393 plays • Length 9:57Download video MP4
Download video MP3
Similar videos
-
7:50
cd28_ amplifying t cell responses for better tumor clearance
-
8:44
ac21 - sophia cornew: ciitizen's clinical trial finder
-
2:01
glycolipid antigen presentation: cd1d & therapeutic potential-nkt cell activation l protocol preview
-
12:45
ac21 - discussion panel: advances in immuno-oncology
-
0:38
nibib supports research leading to novel cancer detection technology
-
2:48
inside inmune bio volume 6 - emacc and cdr-sb
-
9:59
hodgkin's & non hodgkin's lymphoma (hl & nhl), modified ann - arbor staging mnemonics نيمونكس شرح
-
43:39
antigen presentation, t cell activation and deactivation
-
25:19
propresent antigen presentation assay webcast
-
1:27
standardizing protocols for specimen handling for nsclc: acquiring tumor sample
-
13:40
cd155: breaking immune suppression in tumor environments
-
57:56
cancer discovery and preclinical validation using patient-derived xenografts
-
1:25
characterizing tumor-infiltrating lymphocytes in resectable early stage nsclc
-
1:07:33
a new paradigm for the priming of systemic cd8 t cell responses
-
![reliable analysis of antigen-specific t cells in immuno-oncology [webinar]](https://i.ytimg.com/vi/7-NNQ6GT_sg/mqdefault.jpg)
32:03
reliable analysis of antigen-specific t cells in immuno-oncology [webinar]
-
42:06
transcriptional regulation of cd8 t cell immunity to pathogen and tumors | ananda goldrath
-
42:43
investigating immunomodulatory antibodies for cancer therapy
-
58:44
assessing antigen-specific t-cell functionality with dendritic cell/cd8⁺ t cell co-culture
-
3:52
tcan1042 and tcan1051 conducted immunity performance
-
34:24
tumor immunity at single cell resolution - christina leslie - ssci - keynote - ismb 2022
-
0:58
vision trial produces positive data in nsclc with met exon 14 mutations